http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16174275

Outgoing Links

Predicate Object
contentType Letter|Research Support, Non-U.S. Gov't
endingPage 592
issn 1464-5491
0742-3071
issueIdentifier 4
pageRange 591-592
publicationName Diabetic medicine : a journal of the British Diabetic Association
startingPage 591
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4ecf8f8525150e717e69db96af88bd97
bibliographicCitation Smits MM, Tonneijck L, Muskiet MH, Diamant M, Kramer MH, Cahen DL, van Raalte DH. Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes. Diabet Med. 2017 Apr;34(4):591–2. PMID: 27278095; PMCID: PMC5363237.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daf6a763f282266d1a0c0aba869f7ece
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d91f89ab12a79976b37aba0c41c620a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afb67cffe98fc3fcbd596ba7a6d8b806
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0a1d615c793c6aa0bbafec1497a27e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_815351d644121e7a5b55fc486b162eb8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd4bea8ddbc785416dc09cdf5b97c1ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0eca917036bbe7de9845f0f809686db
date 2017-03-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC5363237
https://pubmed.ncbi.nlm.nih.gov/27278095
https://doi.org/10.1111/dme.13160
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3095
https://portal.issn.org/resource/ISSN/1464-5491
https://portal.issn.org/resource/ISSN/0742-3071
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
discusses http://id.nlm.nih.gov/mesh/M0016238
http://id.nlm.nih.gov/mesh/M0012545
http://id.nlm.nih.gov/mesh/M0010903
http://id.nlm.nih.gov/mesh/M0022590
http://id.nlm.nih.gov/mesh/M0001046
http://id.nlm.nih.gov/mesh/M000600817
http://id.nlm.nih.gov/mesh/M0199975
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000067757Q000819
http://id.nlm.nih.gov/mesh/D000681Q000097
http://id.nlm.nih.gov/mesh/D003924Q000188
http://id.nlm.nih.gov/mesh/D014688Q000009
http://id.nlm.nih.gov/mesh/D010455Q000627
http://id.nlm.nih.gov/mesh/D007004
http://id.nlm.nih.gov/mesh/D010455Q000009
http://id.nlm.nih.gov/mesh/D014688Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000077270
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D003924Q000201
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D008049Q000097
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53396299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45588096
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138394057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56927919

Showing number of triples: 1 to 56 of 56.